Initial investigations and clinical outcome in COVID-19 patients


  • Vijay K. Shrivas Department of Medicine, Apollo Hospitals Bilaspur, Chhattisgarh, India
  • Manoj K. Rai Department of Medicine, Apollo Hospitals Bilaspur, Chhattisgarh, India
  • Sandhya Chandel Department of Medicine, Apollo Hospitals Bilaspur, Chhattisgarh, India



Initial investigations, Clinical outcome, COVID-19


Background: Coronavirus disease 2019 (COVID-19) has significant impact on the health infrastructure all over the world including India. We wanted to see whether the routine initial investigations done in COVID 19 patients reflect the prognosis and outcome of the patient.

Methods: It is a retrospective study involving the confirmed covid 19 patients admitted between April 2021 to May 2021. The initial investigations done at the time of admission were studied in relation to outcome of the patient in the form of survival or death of the patient.

Results: A total of 364 patients were studied. 295 (81.05%) patients survived and 69 (18.96%) patients died. Highest mortality was observed in 60% of patients with hemoglobin below 7.0 mg/dl, 40.00% of patients with platelet count below 50000/cml, 28.80% with neutrophil lymphocyte ratio more than 5.5, 32.81% with CRP more than 100 mg/L, 100% with D dimer more than 5000 ng/ml, 33.33% with Ferritin more than 1500 ng/ml, 29.54% with IL-6 more than 100 pg/ml, 23.14% with Random blood sugar more than 200 mg/dl, 37.50% with creatinine more than 2.0 mg/dl, 75% with Bilirubin more than 2.0 mg/dl, 42.85% with SGOT more than 201 mg/dl, 22.22% with SGPT more than 201 mg/dl, 38.46% with serum Procalcitonin more than 2.0 mg/dl. CT Chest severity score of 21 to 30 and 31 to 40 lead to mortality of 19.51% and 40.00% respectively.

Conclusions: The physician who is taking care of COVID-19 patients must get extra cautious regarding prognosis if he gets above initial parameters deranged in isolation or combination.  


Author Biography

Vijay K. Shrivas, Department of Medicine, Apollo Hospitals Bilaspur, Chhattisgarh, India




WHO Coronavirus (Covid-19) Dashboard. Available at Accessed on 20 December 2021.

Londhey V, Redkar N, Gulhane S. Analysis of covid deaths: A single center experience in Mumbai Medical College. JAPI. 2021;69:437-9.

Faghih MD, Somi MH, Majid S. Anemia predicts poor outcomes of covid 19 hospitalised patients: a prospective study in Iran. BMC Infect Dis. 2021;21:170.

Bin Zhu, Feng X, Jiang C. Correlation between white blood cell count at admission and mortality in covid 19 patients: a retrospective study. BMC infect Dis. 2021;21:574.

Imran MM, Ahmad U, Ali M. NLR – A marker of covid 19 pneumonia severity. Int j Clin Pract. 2021;75(4):e13698.

Xia X, Wen M, Zhan S, He J, Chen W. An increased Neutrophil/Lymphocyte ratio is an early warning signal of severe COVID 19. 2020;40(3):333-6.

Cheng B, Hu J, Zuo X, Chen J, Li X, Chen Y et al. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Microbiol Infect. 2020;26(10):1400-5.

Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y et al. CRP correlates with CT findings and predicts severe covid 19 early. J Med Virol. 2020;92(7):856-862.

Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D et al. D dimer as a biomarker for assessment of covid 19 prognosis: D dimer levels on admission and its role in predicting disease outcome in hospitalized patients with covid 19. PLoS ONE. 2021;16(8):e0256744.

Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Angello Z. D dimer concentrations and covid 19 severity: A systematic review and Meta analysis. 2021;12:2-12.

Dahan S, Segal G, Katz I, Hellou T, Tietel M, Bryk G et al. Ferritin as a marker of severity in covid 19 patients A Fatal correlation. Isr Med Assoc J. 2020;22(8):494-500.

Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X et al. Increased levels of ferritin on admission predicts ICU mortality in patients with covid 19. Med Clin (Barc). 2021;156(7):324-31.

Cruz AS, Frias AM, Isabel A, Dias L, Matos AR, Carvalho A et al. Front Immunol. 2021;9:12-4.

Liu X, Wang H, Shi S, Xiao J. Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis. Postgrad Med J 2021;1-9.

Lazarus G, Audrey J, Wangsaputra VK, Tamara K, Tahapary DL. High admission blood glucose independently predicts poor prognosis in covid 19 patients: A systematic review and meta analysis. Diabetes Res Clin Pract. 2021;171:108561.

Cai Y, Shi S, Yang F, Yi B, Chen X, Li J et al. FBG is a predictor of mortality in patients with covid 19 independent of diabetes history. Diabetes Res Clin Pract. 2020;169:108437.

Xiang, HX, Fei J, Xiang Y. Renal dysfunction and prognosis of covid 19 patients: A hospital based retrospective cohort study. BMC Infect Dis. 2021;21:158.

Liu Z, Li J, Long W, Zeng W. Front Med (Lausanne). 2020;7:598870.

Salik F, Uzundere O, Bicak M, Akelma H, Akgunduz H et al. Liver function as a predictor of mortality in covid 19: A retrospective study. Annals of Hepatology. 2021;10:21-9.

Ahmad S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic value of serum procalcitonin in covid 19 patients: A systematic review. Indian J Crit Care Med. 2021;25(1):77-84.

Heidari-Beni F, Vahedian-Azimi A, Shojaei S, Bashar RF. The level of Procalcitonin in Severe covid 19 patients: A systematic review and Meta analysis. Adv Exp Med Biol. 2021;1321:277-86.

Yang R, Li X, Liu H, Zhen Y. Chest CT severity Score: An Imaging Tool for assessing severe covid 19. Apr 2020. Rad Cardiothoracic Imag. 2020;2(2):e200047.






Original Research Articles